highlighted below; (Unit : Million Baht) Separate financial statements Q3/2018 Q3/2017 % Change Sales and Service income 462 514 (10) Cost of Sales and Services 363 405 (12) Selling and Administrative Expenses

) Total revenue 1,819,624 1,272,735 546,889 42.97 Total Cost & Expense 1,685,730 1,222,945 462,785 37.84 Selling & Admin. Expense 303,598 257,018 46,580 18.12 Finance cost 77,519 72,753 4,766 6.55 Net

effective mall management and operating cost control despite major renovations at CentralWorld and CentralPlaza Rama 3 The Thai economy in 3Q17 continued to expand courtesy of solid growth in export of goods

quarter 3/2018, as of February 28, 2018, which were reviewed by the auditor. 2. Has approved to propose to the shareholders meeting for ratification in the disposition of shares in Thai bonnet Trading Zone

213,102 512,053 (298,951) (58.38) Gross profit margin (%) 33.25 28.50 4.75 16.66 Total revenue 666,277 1,819,624 (1,153,347) (63.38) Total Cost & Expense 719,232 1,685,730 (966,498) (57.33) Selling & Admin

’ environment. CPN successfully maintain an effective capital structure and flexible financing cost structure, as well as prepare adequate funding to support the investment plan and lower the financing cost at

to generate revenue stream amidst softened tourism sentiment. However, both hotels showed effective cost control in both room and food and beverage management. Cost of sales In 3Q19, CPN reported costs

strongly, especially on a same-store basis that continues to grow together with cost effective management. Excluding the non-recurring items, total revenue increased 9.0% YoY and net profit increased 7.4

malls (i.e. common areas, convention halls, on-site-media, and promotional areas) by continuously rolling out a variety of marketing events in all projects. Continual effective cost management The lower

profits by 12.5% as a result of higher efficiency gains from effective cost controls, despite a decrease in total revenue by 3.4% primarily due to the decline in revenue from sales, consistent with the